Over the counter medication


June 2005

References
  • Adcock H (2001) OTC medicines misuse and addiction: what can pharmacists do to help? The Pharmaceutical Journal 267: 457.
  • Adcock H (2004) Self care goes under the microscope. The Pharmaceutical Journal 273: 715.
  • Anderson MR, Klink K & Cohrssen A (2004) Evaluation of vaginal complaints. JAMA 291: 1368.
  • Anonymous (1994a) Protocols and staff training to be added to Code of Ethics. The Pharmaceutical Journal 252: 124.
  • Anonymous (1994b) Introductory protocol points. The Pharmaceutical Journal 253: 805.
  • Anonymous (1994c) Society issues press release on protocols. The Pharmaceutical Journal 251: 127.
  • Anonymous (1995) POM-to-P shift proposed for budesonide and P-to-POM for carbaryl. The Pharmaceutical Journal 255: 138.
  • Anonymous (1997) Terfenadine switches back to POM. The Pharmaceutical Journal 259: 316.
  • Anonymous (2000) Third pharmacy-based EHC pilot about to start in Derbyshire. The Pharmaceutical Journal 264: 712.
  • Anonymous (2001) Pharmacy-based head lice management. The Pharmaceutical Journal 267: 317.
  • Anonymous (2002) Pharmacists in Scotland target low income pregnant women who smoke. The Pharmaceutical Journal 269: 182.
  • Aronson JK (2004) Over-the-counter medicines. Br J Clin Pharmacol 58: 231-4.
  • Barnett NL, Denham MJ & Francis SA (2000) Over-the-counter medicines and the elderly. J R Coll Physicians Lond 34: 445-6.
  • Bayliss E & Rutter P (2004) General practitioners’ views on recent and proposed medicine switches from POM to P. The Pharmaceutical Journal 273: 819-21.
  • Beitz R, Doren M & Knopf H et al (2004) Over-the-counter self medication in Germany. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 47: 1043-50.
  • Birchley N & Conroy S (2002) Parental management of over-the-counter medicines. Paediatr Nurs 14: 24-8.
  • Bissell P, Ward PR & Noyce P (2001) The dependent consumer: reflections on accounts of the risks of non-prescription medicines. Health 5: 5-30.
  • Bond CM & Grimshaw JM (1994) Clinical guidelines for the treatment of dyspepsia in community pharmacies. The Pharmaceutical Journal 252: 228-9.
  • Bousquet J (on behalf of Aria workshop members) (2004) ARIA in the pharmacy; management of allergic rhinitis symptoms in the pharmacy. Allergy 59: 373-87.
  • Bradley C, Kenkre J & Tobias R et al (1996) GPs’ rate of recommending over the counter drugs varies. BMJ 313: 115-6.
  • Bradley CP, Riaz A & Tobias RS et al (1998) Patient attitudes to over-the-counter drugs and possible professional responses to self-medication. Fam Pract 15: 44-50.
  • Branstad JO, Kamil I & Lilja J et al (1994) When topical hydrocortisone became an OTC drug in Sweden – a study of the users and their information sources. Soc Sci Med 39: 207-12.
  • Brass EP (2001) Changing the status of drugs from prescription to over-the-counter availability. New England Journal of Medicine 345: 810-6.
  • Brass EP (2004) Consumer behaviour in the setting of over-the-counter statin availability. Am J Cardiol 94: 22F-29F.
  • Breckenridge A (2002) CSM advice on liver toxicity associated with kava-kava and proposed regulatory action by the government committee on safety of medicines. CEM/CMO/2002/10.
  • Checkland K (2002) The gap between practice and research. bmj.bmjjournals.com/cgi/eletters/324/7333/329
  • Cohen JP, Paquette C & Cairns CP (2005) Switching prescription drugs to over the counter. BMJ 330: 39-41.
  • Committee for Safety of Medicines and Medicines Control Agency (1992) Astemizole and terfenadine. Current problems in pharmacovigilance. London: Committee on Safety of Medicines.
  • Committee on Safety of Medicines (2000) Reminder St John’s Wort interactions. Current Problems in Pharmacovigilance. London: Committee on Safety of Medicines: May 26:5
  • Committee on Safety of Medicines (2004) Advice on the use of celecoxib and other selective COX-2 inhibitors in the light of concerns about cardiovascular safety. Letter to health care professionals Celecoxib epinet 20/12/04.
  • Davies NM & Jamali F (2004) COX-2 selective inhibitors cardiac toxicity: getting to the heart of the matter. Journal of Pharmaceutical Science 7: 332-6
  • Department of Health (2004) Making the best use of the pharmacy workforce. (page 14).
  • Egberts TCG, Smulders M & de Koning FHP et al (1996) Can adverse drug reactions be detected earlier? A comparison of reports by patients and professionals. BMJ 313: 530-1.
  • Emmerton L & Shaw J (2002) The influence of pharmacy staff in non-prescription medicine sales. Int J Pharm Pract 10: 101-6.
  • Erwin J, Britten N & Jones R (1996) General practitioners’ views on over the counter sales by community pharmacists. BMJ 312: 617-8.
  • Erwin J, Britten N & Jones R (1997) General practitioners’ views on over the counter availability of H2 antagonists. Br J Gen Pract 47: 99-102.
  • European Community (1992) Directive for medicines classification. 92/26/EEC of 31 March 1992 concerning the classification for the supply of medicinal products for human use, OJ L 113, 30 April 1992.
  • Fendrick AM, Shaw M & Schnactel B et al (2004) Self-selection and use patterns of over-the-counter omeprazole for frequent heartburn. Clin Gastroenterol Hepatol 2: 17-21.
  • Fenichel RR (2004) Which drugs should be available over the counter. BMJ 329: 182-3.
  • Gore P & Madhavan S (1993) Credibility of the sources of information for non-prescription medicines. J Soc Admin Pharm 10: 109-22.
  • Grieve D (2004) Over Count statistical returns.
  • Hassell K, Noyce P & Rogers A (1999) A review of factors that influence the use of community pharmacy as a primary health care resource. Int J Pharm Pract 7: 51-9.
  • Hassell K, Whittington Z & Cantrill J et al (2001) Managing demand: transfer of management of self limiting conditions from general practice to community pharmacies. BMJ 323: 146-7.
  • Henley E & Wenzel-Wamhoff J. Teaching medical students about over-the-counter medication. Med Educ (2000) 34: 580-2
  • Hughes GF, McElnay JC & Hughes CM et al (1999) Abuse/misuse of non-prescription drugs.
  • Pharm World Sci 21: 251-5.
  • Kilby S (2005) Royal Pharmaceutical Society of Great Britain (Personal communication).
  • Lefterover A & Getov I (2004) Study on consumers’ preferences and habits for over the counter analgesics use. Cent Eur J Public Health 12: 43-5.
  • Li Wan Po A & Zhang WY (1996) Paracetamol-codeine combinations versus paracetamol alone. BMJ 313: 1209.
  • Little P, Gould C & Williamson I et al (1997) Reattendance and complications in a randomised trial of prescribing strategies for sore throat: the medicalising effect of prescribing antibiotics. BMJ. 315: 350-2.
  • Mann R & Andrews E Pharmacovigilance handbook. CHIPSBOOKS
  • Matheson C, Bond CM & Pitcairn J (2002) Misuse of over the counter medicines from community pharmacies: a population survey of Scottish Pharmacies. The Pharmaceutical Journal 269: 66-8.
  • Matheson C & Bond CM (1995) Lower gastrointestinal symptoms. The Pharmaceutical Journal 253: 656-8.
  • McBride AJ, Pates R & Ramadan R et al (2003) Delphi survey of experts’ opinions on strategies used by community pharmacists to reduce over-the-counter drug misuse. Addiction 98: 487.
  • Medicines and Healthcare products Regulatory Agency (MHRA). Policy on legal status of medicines. http://medicines.mhra.gov.uk (accessed 14/1/05).
  • Moore N, Van Ganse E & Le Parc JM et al (1999) The PAIN study: paracetamol, aspirin and ibuprofen new tolerability study. Clinical Drug Investment 18: 89-98.
  • Morgan, Oliver & Griffiths et al (2005) Impact of paracetamol pack size restrictions on poisoning from paracetamol in England and Wales: an observational study. J Public Health Med 27: 19-24.
  • Morley A, Jepson MH & Edwards C et al (1984) Should pharmacists treat minor ailments? Chemist and Druggist. 82-4.
  • Morris CJ, Cantrill JA & Weiss MC (1997) One simple question should be enough: consumers’ perceptions of pharmacy protocols. Int J Pharm Pract 5: 64-71.
  • National Pharmaceutical Association (2004) Implementing a Minor Ailment scheme: a practical toolkit for primary care organisations.
  • Pates R, McBride A & Li S et al (2002) Misuse of over the counter medicines: a survey of community pharmacies in a South Wales health authority. The Pharmaceutical Journal 268: 179-82.
  • Payne K, Ryan-Woolley B & Noyce P (1998) Role of consumer attributes in predicting the uptake of medicines deregulation and National Health Service prescribing in the United Kingdom. Int J Pharm Pract 6: 150-8.
  • Phelan M, Akram G & Lewis M et al (2002) A community pharmacy based survey of users of over-the-counter sleep aids. The Pharmaceutical Journal 269: 287-90.
  • Pillitteri JL, Kozlowski LT & Person DC et al (1994) Over-the-counter sleep aids: widely used but rarely studied. J Subst Abuse 6: 315-23.
  • Porteous T, Bond CM & Hannaford P et al (2005) How and why are non-prescription analgesics used in Scotland? Family Practice.
  • Porteous T, Bond CM & Sinclair H et al (2002) Non-prescribed analgesics: how and why are they used? Report to Chief Scientist Office. London: HMSO.
  • Porteous T, Bond CM & Hannaford P et al (2003) Electronic transfer of prescription related information: comparing the views of patients, GPs and pharmacists. Br J Gen Pract 53: 204-9.
  • Porteous T, Bond CM & Duthie I et al (1997) Guidelines for the treatment of hayfever and other allergic conditions of the upper respiratory tract. The Pharmaceutical Journal 259: 62-5.
  • Porteous T, Bond CM & Duthie I et al (1998) Guidelines for the treatment of self limiting upper respiratory tract ailments. The Pharmaceutical Journal 260: 134-9.
  • Pradel FG, Hartzema AG & Mutran EJ et al (1999) Physician over-the-counter prescribing patterns: an analysis of the National Ambulatory Medical Care Survey. Ann Pharmacother 33: 400-5.
  • Prayle D & Brazier M (1998) Supply of medicines: paternalism, autonomy and reality. J Med Ethics 24: 93-8
  • Proprietary Association of Great Britain (2004). Self Care Review. London: PAGB.
  • Protocols and staff training to be added to Code of Ethics. The Pharmaceutical Journal 252: 124.
  • Rallapalli KC & Smith MC (1994) OTC drug advertising-information content. J Soc Admin Pharm 11: 139-47.
  • Rogers PJ, Wood SM & Garrett E et al (2004) Awareness and recommendation of over-the-counter topical steroids by general practitioners and community pharmacists. Int J Pharm Pract 12: R14.
  • Roumie CL & Griffin MR (2004) Over the counter analgesics in older adults: a call for improved labelling and consumer education. Drugs Aging 21: 485-98.
  • Royal Pharmaceutical Society of Great Britain (2000) Prescription only medicines reclassified to pharmacy only medicines.
  • Royal Pharmaceutical Society of Great Britain (2004) Code of Ethics Service Specification. 10 July 2004 no 98.
  • Sansgiry S, Sharp WT & Sansgiry SS (1999) Department of Pharmacy Practice and Administrative Sciences, College of Pharmacy, Idaho State University. Health Mark Q 17: 7-18.
  • Sansgiry SS & Cady PS (1996) How the elderly and young adults differ in the decision-making process of non-prescription medication purchases. Health Mark Q 14: 3-21.
  • Schafheutle E, Cantrill, J & Nicolson M et al (1996) Insights into the choice between self medication and a doctor’s prescription: a study of hay fever sufferers. Int J Pharm Pract 4: 156-61.
  • Schafheutle EI, Noyce PR & Sheehy C et al (2002) Users and costs of the Scottish Direct Supply of Medicines scheme. Int J Pharm Pract 10: R63.
  • Shaw J & Baker M (2004) Expert patient – dream or nightmare? BMJ 328: 723-4
  • Shih YC, Prasad M & Luce BR (2002) The effect on social welfare of a switch of second-generation antihistamines from prescription to over-the-counter status: a microeconomic analysis. Clinical Therapy 24: 701-16.
  • Sihvo S, Hemminki E & Ahonen R (1999) Physicians’ attitudes toward reclassifying drugs as over-the-counter. Med Care 37: 518-25.
  • Sinclair H, (2003) (personal communication) from Sinclair H, Urquhart G & Hannaford P. The use of non-prescription medicines by GP attendees. Forthcoming publication based on BMed Sci thesis, University of Aberdeen (GU) 2001.
  • Sinclair H, Lawton S & Bond CM et al. Patient reported satisfaction of treatments for allergic rhinitis provided from community pharmacies. [Submitted to IJPP]
  • Sinclair HK, Bond CM & Hannaford PC (2000) Over the counter ibuprofen: how and why is it used? Int J Pharm Pract 8: 121-7.
  • Sinclair HK, Bond CM & Hannaford PC (2001) Long term follow up studies of users of non-prescription medicines purchased from community pharmacies: some methodological issues. Drug Safety 24: 929-39.
  • Sleath B, Rubin RH & Campbell W et al (2001) Physician-patient communication about over-the-counter medications. Soc Sci Med 53: 357-69.
  • Spencer JA & Edwards C (1992) Pharmacy beyond the dispensary: general practitioners’ views. BMJ 304: 1670-2.
  • Stevenson FA, Britten N & Barry CA et al (2003) Self-treatment and its discussion in medical consultations: how is medical pluralism managed in practice? Soc Sci Med 57: 513-27.
  • Strom BL (1989) Choosing among the available approaches for pharmacoepidemiologic studies.
  • In: B L Strom (ed.) Pharmacoepidemiology. New York: Churchill Livingstone: pp 245-56.
  • Taylor J (1994) Reasons consumers do not ask for advice on non-prescription medicines. Int J Pharm Pract 2: 209-14
  • Urquhart G, Sinclair HK & Hannaford PC (2004) The use of non-prescription medicines by general practitioner attendees. Pharmacoepidemiology and Drug Safety 13: 773-9.
  • Walker A, Watson MC & Grimshaw J et al (2004) Applying the theory of planned behaviour to pharmacists’ beliefs and intentions about the treatment of vaginal candidiasis with non prescription medicines. Family Practice 21: 1-7.
  • Walker R, Evans S & Kirkland D (2003) Evaluation of ‘Care at the pharmacy’ in Gwent on the management of self limiting conditions and workload of a general medical practice. Int J Pharm Pract 11: R7.
  • Watson MC, Grimshaw JM & Bond CM et al (2002) Oral versus intra-vaginal imidazole and triazole anti-fungal agents for the treatment of uncomplicated vulvovaginal candidiasis (thrush): a systematic review. BJOG 109: 85-95.
  • Watson MC, Grimshaw JM & Bond CM et al (2002) Oral versus intra-vaginal imidazole and triazole anti-fungal treatment of uncomplicated vulvovaginal candidiasis (thrush). Cochrane Database Syst Rev 4: CD002845 (latest version 28 May 2001).
  • Watson MC, Bond CM & Grimshaw JM et al (2002) Educational strategies to promote evidence-based community pharmacy practice: a cluster randomised controlled trial (RCT). Family Practice 19: 529-36.
  • Watson MC & Bond CM on behalf of the members of the Grampian Evidence Based Community Pharmacy Guidelines Group (2003). Evidence-based guidelines for the over-the-counter treatment of vulvovaginal candidiasis. Pharmacy World and Science 25: 129-34.
  • Watson MC & Bond CM (2004) The evidence based supply of non-prescription medicines: barriers and beliefs. Int J Pharm Pract 12: 65-72.
  • Whittington Z, Cantrill J & Hassell KJ et al (2001) Community pharmacy management of minor conditions – the ‘care at the Chemist’ scheme. The Pharmaceutical Journal 266: 425-8.

Log in to your BMA here